Anti-PD-1 antibody significantly increases therapeutic efficacy of Listeria monocytogenes (Lm)-LLO immunotherapy
| dc.contributor.author | Mkrtichyan, Mikayel | |
| dc.contributor.author | Chong, Namju | |
| dc.contributor.author | Abu Eid, Rasha | |
| dc.contributor.author | Wallecha, Anu | |
| dc.contributor.author | Singh, Reshma | |
| dc.contributor.author | Rothman, John | |
| dc.contributor.author | Khleif, Samir N. | |
| dc.date.accessioned | 2018-04-09T10:43:08Z | |
| dc.date.available | 2018-04-09T10:43:08Z | |
| dc.date.issued | 2013-08-29 | |
| dc.description | This work was supported by the Intramural Research Program of the Center for Cancer Research, NCI, NIH, Georgia Regents University Cancer Center (GRUCC) and Advaxis Inc. RAE is supported by a Fellowship Grant from King Hussein Institute for Biotechnology and Cancer (KHIBC, Jordan). | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 9 | |
| dc.format.extent | 933938 | |
| dc.identifier | 72366643 | |
| dc.identifier | 19ba9e42-ee3a-42ee-9d6a-fec47fbe1fef | |
| dc.identifier | 24829751 | |
| dc.identifier | 84991038640 | |
| dc.identifier.citation | Mkrtichyan, M, Chong, N, Abu Eid, R, Wallecha, A, Singh, R, Rothman, J & Khleif, S N 2013, 'Anti-PD-1 antibody significantly increases therapeutic efficacy of Listeria monocytogenes (Lm)-LLO immunotherapy', Journal for immunotherapy of cancer, vol. 1, 15, pp. 1-9. https://doi.org/10.1186/2051-1426-1-15 | en |
| dc.identifier.doi | 10.1186/2051-1426-1-15 | |
| dc.identifier.issn | 2051-1426 | |
| dc.identifier.other | PubMedCentral: PMC4019896 | |
| dc.identifier.uri | http://hdl.handle.net/2164/10308 | |
| dc.identifier.url | http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4019896&tool=pmcentrez&rendertype=abstract | en |
| dc.identifier.url | http://www.mendeley.com/research/antipd1-antibody-significantly-increases-therapeutic-efficacy-listeria-monocytogenes-lmllo-immunothe | en |
| dc.identifier.vol | 1 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Journal for immunotherapy of cancer | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | PD-1 | en |
| dc.subject | Immunotherapy | en |
| dc.subject | Listeria-based vaccine | en |
| dc.subject | Combinational immunotherapy | en |
| dc.subject | QR180 Immunology | en |
| dc.subject | RC0254 Neoplasms. Tumors. Oncology (including Cancer) | en |
| dc.subject.lcc | QR180 | en |
| dc.subject.lcc | RC0254 | en |
| dc.title | Anti-PD-1 antibody significantly increases therapeutic efficacy of Listeria monocytogenes (Lm)-LLO immunotherapy | en |
| dc.type | Journal article | en |
